NervGen Pharma Corp. (NGEN)
NASDAQ: NGEN · Real-Time Price · USD
2.125
-0.005 (-0.23%)
Sep 10, 2026, 10:37 AM EDT - Market open
NervGen Pharma Market Cap
NervGen Pharma has a market cap or net worth of $228.49 million as of September 10, 2026. Its market cap has increased by 16.35% in one year.
Market Cap
228.49M
Enterprise Value
167.37M
1-Year Change
16.35%
Ranking
Category
Stock Price
$2.13
ChartMarket Cap Chart
Since April 3, 2019, NervGen Pharma's market cap has increased from $37.43M to $228.49M, an increase of 510.44%. That is a compound annual growth rate of 27.51%.
| Date | Market Cap | % Change |
|---|---|---|
| Sep 10, 2026 | 228.49M | -48.74% |
| Dec 31, 2025 | 445.73M | 190.81% |
| Dec 31, 2024 | 153.27M | 26.05% |
| Dec 29, 2023 | 121.60M | 74.14% |
| Dec 30, 2022 | 69.83M | -27.73% |
| Dec 31, 2021 | 96.62M | 58.13% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Apr 3, 2019 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| Invivyd | 243.41M |
| Surrozen | 243.06M |
| Compugen | 242.49M |
| Cellectis | 238.44M |
| Eledon Pharmaceuticals | 238.33M |
| Neumora Therapeutics | 234.87M |
| Adagene | 234.33M |
| Greenwich LifeSciences | 233.38M |